Kezar Life Sciences, Inc.
SEC Filing List
KZR CIK: 0001645666
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SC TO-T | Third party tender offer statement | Aurinia Pharmaceuticals Inc. | Broadridge Financial Solutions, Inc. /fa | 04/13/2026 | |
| SCHEDULE 13G | M2 COMPLIANCE LLC /fa | 04/06/2026 | |||
| SCHEDULE 13G | M2 COMPLIANCE LLC /fa | 04/06/2026 | |||
| 8-K | Current report filing | Kezar Life Sciences, Inc. | Workiva Inc. Wdesk FA01 /fa | 04/03/2026 | |
| SC14D9C | Written communication by the subject com... | Kezar Life Sciences, Inc. | Workiva Inc. Wdesk FA01 /fa | 04/03/2026 | |
| SCHEDULE 13D/A | SECUREX FILINGS /fa | 04/01/2026 | |||
| 8-K | Current report filing | Kezar Life Sciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/30/2026 | |
| SC14D9C | Written communication by the subject com... | Kezar Life Sciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/30/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Kezar Life Sciences, Inc. | Workiva Inc. Wdesk FA01 /fa | 03/27/2026 | |
| 8-K | Current report filing | Kezar Life Sciences, Inc. | Workiva Inc. Wdesk FA01 /fa | 03/12/2026 | |
| No record found. | |||||
| Load More | |||||
